Dr. Wu Skincare Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,168	1,242	1,137	926.79	1,106
Revenue Growth (YoY)	-5.92%	9.20%	22.70%	-16.20%	44.65%
Cost of Revenue	362.67	363.68	323.12	268.78	411.65
Gross Profit	805.59	878.08	814.02	658.02	694.36
Selling, General & Admin	368.92	341.04	314.88	278.22	307.89
Research & Development	9.57	12.09	9.12	7.24	10.02
Operating Expenses	378.52	353.08	324.05	285.39	317.98
Operating Income	427.07	525	489.98	372.63	376.38
Interest Expense	-1.39	-0.82	-0.26	-0.52	-0.76
Interest & Investment Income	36.81	37.44	32.66	10.6	7.81
Currency Exchange Gain (Loss)	-	32.21	2.22	44.56	-6.09
Other Non Operating Income (Expenses)	-21.07	0.4	0.27	-1.31	-3.16
EBT Excluding Unusual Items	441.41	594.24	524.87	425.97	374.19
Gain (Loss) on Sale of Investments	0.07	1.09	0.89	-1.88	-1.06
Gain (Loss) on Sale of Assets	-	-	-	-	-0.14
Asset Writedown	-	-	-	-	-0.97
Other Unusual Items	-	-	0.01	-	-
Pretax Income	441.49	595.32	525.77	424.08	372.03
Income Tax Expense	91.21	119.07	101.03	84.1	75.78
Net Income	350.27	476.25	424.73	339.98	296.24
Net Income to Common	350.27	476.25	424.73	339.98	296.24
Net Income Growth	-26.45%	12.13%	24.93%	14.77%	-55.19%
Shares Outstanding (Basic)	45	45	45	45	45
Shares Outstanding (Diluted)	45	45	45	45	45
Shares Change (YoY)	0.04%	0.19%	-0.02%	-0.02%	-0.16%
EPS (Basic)	7.78	10.57	9.43	7.55	6.58
EPS (Diluted)	7.75	10.54	9.42	7.54	6.57
EPS Growth	-26.47%	11.89%	24.93%	14.76%	-55.09%
Free Cash Flow	335.01	434.43	389.49	324.24	290.92
Free Cash Flow Per Share	7.41	9.62	8.64	7.19	6.45
Dividend Per Share	-	11.000	10.000	8.000	13.220
Dividend Growth	-	10.00%	25.00%	-39.49%	230.50%
Gross Margin	68.96%	70.71%	71.58%	71.00%	62.78%
Operating Margin	36.56%	42.28%	43.09%	40.21%	34.03%
Profit Margin	29.98%	38.35%	37.35%	36.68%	26.78%
Free Cash Flow Margin	28.68%	34.98%	34.25%	34.98%	26.30%
EBITDA	436.73	528.18	494.25	377.16	383.47
EBITDA Margin	37.38%	42.54%	43.46%	40.70%	34.67%
D&A For EBITDA	9.65	3.18	4.27	4.53	7.09
EBIT	427.07	525	489.98	372.63	376.38
EBIT Margin	36.56%	42.28%	43.09%	40.21%	34.03%
Effective Tax Rate	20.66%	20.00%	19.22%	19.83%	20.37%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.